戻る
Bristol-Myers Squibb and BioNTech Advance Oncology Pipeline Amidst New Autoimmune Venture
戻る
株式ニュース
テーマ
Bristol-Myers Squibb and BioNTech Advance Oncology Pipeline Amidst New Autoimmune Venture
がん研究
Bristol-Myers Squibb and BioNTech Advance Oncology Pipeline Amidst New Autoimmune Venture
Edgen Stock
·
Sep 18 2025, 13:37
共有先
共有先
リンクをコピー
ソース：
[1] Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction
[2] Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction - Insider Monkey
[3] BMS and Bain Capital form new biotech company for autoimmune therapies - Investing.com
Edgen Stock·Sep 18 2025, 13:37Edgen Stock·Sep 18 2025, 13:37
Edgen Stock·Sep 18 2025, 13:37